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Oral cancer patient’s profile and time to
treatment initiation in the public health
system in Rio de Janeiro, Brazil
Manoela Garcia Dias da Conceição1 , Isabel Cristina Martins Emmerick2 , Ana Claudia Figueiró3 and
Vera Lucia Luiza4*
Abstract
Background: This paper aims to describe the profile of oral cancer (OC) patients, their risk classification and
identify the time between screening and treatment initiation in Rio de Janeiro Municipality.
Method: Data were obtained from the healthcare Regulation System (SISREG) regarding the period January 2013 to
September 2015. Descriptive, bivariate and multivariate analysis were performed identifying the factors associates
with a diagnosis of OC as well as the time to treatment initiation (TTI) differences between groups.
Results: From 3,862 individuals with a potential OC lesion, 6.9 % had OC diagnosis. OC patients were 62.3 y.o.
(mean), 64.7 % male, 36.1 % were white and 62.5 % of the records received a red/yellow estimated risk classification.
Being older, male, white and receiving a high-risk classification was associated with having an OC diagnosis. OC TTI
was in average 59.1 days and median of 50 days significantly higher than non-OC individuals (p = 0.007). TTI was
higher for individuals older than 60 years old, male, and white individuals and for risk classification red and yellow,
nevertheless while in average none of these differences were statistically significant, the median of individuals
classified as low risk was significantly (p = 0.044) lower than those with high risk.
Conclusions: Time to treatment initiation (TTI) was higher for OC patients related to non OC. Despite OC
confirmed was associated with risk at screening classified as urgent or emergent, a high percentage of OC patients
had their risk classified for elective care when specialized care was requested.
Keywords: Oral health, Mouth neoplasms, Primary Health Care, Specialized health care
Background
Oral health is part of general health and essential to
people’s well-being. Issues with oral health can have
as consequences: chronic orofacial pain, cancer of the
mouth and pharynx, changes in the soft tissues of the
mouth, congenital disabilities, or other conditions that
affect the craniofacial complex [1], leading to
psychological distress. It has been associated with al-
coholism, use of tobacco products [2] and social ex-
clusion. Among its determinants, deficient schooling,
low income, unemployment, and difficulty in acces-
sing assistance services as well as deficit in self-care
are identified [3, 4].
According to data from the National Cancer Institute
(INCA) for Brazil, in the triennium 2020–2022 there
were an estimated 625 thousands new cases per year [5]
and 225 thousands deaths in 2018 [6]. Almost half of the
incidence of Oral Cancer (OC) occurs in the Southeast
region [6], where Rio de Janeiro Municipality is located.
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Nationwide there were 11,180 OC cases in the male
population and around 4010 in the female population
for the 2020–2022 triennium, being the fifth most preva-
lent among the first [5]. Although the evolution in the
prevalence estimate of OC is discreet, this disease is a
worldwide public health problem due to its high morbid-
ity and mortality [7].
The vulnerability of OC subjects makes it difficult to
provide adequate dental care, either because of their so-
cioeconomic status, challenges in accessing health ser-
vices, or because they do not seek health services [3].
When not treated on time, it is significantly mutilating,
causing damage to these patients’ physical and psycho-
logical aspects and directly interfering with the quality of
life [8].
However, if diagnosed early, OC has a good prognosis,
with the average five-year survival rate in stages I and II
being 77.3 %, but 32.2 % in stages III and IV [9]. As an
early diagnosis of OC is uncommon, with 65 to 85 % of
cases diagnosed in an advanced stage, the likelihood of
cure is reduced [4, 10–12].
In Brazil, Primary Health Care (PHC) is supposed to
have an active role regarding oral health and its actions
include the promotion of oral health and prevention,
care, and rehabilitation. In cases of greater complexity, it
must be able to act in an articulated and swift manner
with the Specialized Dental Clinics (SDCs), which corre-
sponds to secondary care. When appropriate, such as
OC diagnosis, rapid treatment initiation in a cancer cen-
ter is essential. Since 2012, there is in place a federal law
[12] stipulating that in the event of suspected malignant
neoplasia, the diagnostic confirmation test must be car-
ried out within 30 days after medical request and spe-
cific treatment must be started within 60 days after the
positive cancer diagnosis.
The care trajectory consists of patients’ path in the
health care network comprising the use of health care
resources from the onset of the problem to its outcome
[13, 14]. It includes making appointments in oral health,
the time of return to perform referrals, performing biop-
sies and obtaining test results, and continuity of care
after starting treatment for OC [15], which must act ac-
cording to a regulation system of health care delivery.
The timely care is one of the components of access to
the health system. In this study, it was expressed in
terms of the time to treatment initiation (TTI).
Rio de Janeiro is a 6.6 million inhabitants municipality
located in Southeast region. In 2009 a comprehensive
plan for PHC expansion and reorganization was imple-
mented. In addition to a broad set of governmental
health facilities comprising all levels of health care,
National Institute of Cancer (INCA), the main reference
center for cancer care and research in the country, is lo-
cated in this city. Despite of its relevance, TTI studies
are scarce in Brazil and the few [16–19] were performed
in limited populations. This is the first study that evalu-
ate time for treatment initiation in the Rio de Janeiro
municipality, that considered all the susceptible
population.
This study aims to describe the profile of patients
with suspect and confirmed oral cancer, associated fac-
tors and time to treatment initiation (TTI) in public
health system in Rio de Janeiro municipality, Brazil, from
January 2013 to September 2015.
Methods
Data were obtained from the healthcare Regulation Sys-
tem (SISREG) regarding the period from January 2013
to September 2015. This study was part from a broader
one, a PhD dissertation that had the general aim of
evaluating the quality of the care given to patients with
oral cancer (OC) in the city of Rio de Janeiro consider-
ing the dimensions of access and effectiveness of pri-
mary and secondary health care delivery [20].
Setting
Brazil has a National Health Policy Regulation since
2008 comprising three aspects: health system, health
care and access to health care, mediated by an informa-
tion system. SISREG was the patient flow regulation sys-
tems used in the Brazilian Unified Health System (SUS)
until 2015, when was replaced by Rio de Janeiro State
Regulation System (SER) [21]. This change the data
structure and storage, which made the linkage of pre
and post changes complex and unworthy for the purpose
of the source study. Therefore, the analysis used the
complete data prior to this administrative change.
This study concerns to Rio de Janeiro municipality, a
6.6 million inhabitants (population at 2012) Brazilian
City [22] and a complete health services offer, compris-
ing all health care levels.
Oral Care counts on a regionalized and hierarchical
services network, offered in PHC, secondary, high com-
plexity and urgency / emergency health facilities [7].
Secondary OC is provided in Specialized Dental Clinics
(SDC) (Centro de Especialidades Odontológicas (CEO),
in Portuguese), that offer Endodontics, Periodontics,
Minor surgery, Stomatology, Orthodontics and Pros-
theses care as well as care for patients with special needs
[7]. The recommended patient flow is presented in
Fig. 1.
To initiate care, patients must look for their reference
PHC facility which is also supposed to offer health pro-
motion, and disease prevention activities. In case of spe-
cialized care need, the patient must be referred to a
SDC, preferably also close to his home, through SISREG.
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If a more specialized care is required, e.g., cancer treat-
ment, the patient is referred also through SISREG.
The database contained all referral records analyzed in
the regulation system during the interest period by fol-
lowing medical specialties: general head and neck, head
and neck oncology, and dentistry / stomatology.
Variables
The main outcome variable was ‘having oral cancer’.
The following factors were investigated: age (average
and categories), excluding individuals under 15 years
old; race (white vs. non-white) and first risk stratifica-
tion categorized as high risk (red or yellow) and low
risk (green or blue) and TTI. Risk categories are blue
- elective care; green - not urgent; yellow – urgent;
and red – emergent. In Brazil, the variable race is re-
lated with skin color/ethnicity and the recommenda-
tion for its collection is self-declaration by the
interviewee. Despite of the name “race” have been
considered obsolete in the literature, many activists
argue that is important to value this variable in order
to evidence disparities in the context of access to care
and treatment. The time to treatment initiation was
defined as the time between the first request date re-
corded in that database and the last execution date,
what indicates the time between the first appointment
and the moment that the individual was seen in his /
her definitive treatment facility (start of OC
treatment).
Each encounter referred was recorded in SISREG, thus
the same individual can have multiple entries in the sys-
tem and each record receive a risk classification. The
overall risk analysis was performed by encounter. To
perform the bivariate and multivariate statistical analyzes
it was considered the risk evaluation attributed to the
patient in the first encounter.
Analysis
For the first main outcome, the presence of oral cancer,
a descriptive analysis was performed considering the dis-
tribution of age, sex and race, as well as bivariate and
multivariate analysis. The difference of proportions was
expressed by the odds ratio, aiming to identify differ-
ences in the demographics and risk determination be-
tween cancer and non-cancer patients.
The second outcome was the TTI, and this analysis
comprised a descriptive analysis (mean and median) by
presence of oral cancer diagnosis. For those with a posi-
tive diagnosis of oral cancer, it was performed the non-
parametric test of median difference and T-test of the
mean to verify if the TTI was different between groups
by the age, sex and race. As the distribution of the vari-
able waiting time was heterogeneous, mean and median
were very different it was made the option of statistically
Fig. 1 Recommended flow of care for lesions suspected of oral cancer. OC = Oral Cancer; PDC = Primary Dental Care; SDC = Specialized
Dental Clinics
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test the T-test (mean) and the non-parametric tests for
median differences.
All statistical analyses were performed at 95 % of con-
fidence interval using SPSS V.22.
Ethical issues
The source study was approved by three Ethical Re-
search Committees, the first from academic institution,
the National School of Public Health Sergio Arouca ERC
(CAAE 59009416.6.0000.5240), the second from the Na-
tional Institute of Cancer ERC (CAAE
59009416.6.3001.5274), the hospital where patients were
sampled for the face-to-fac interview (data not included
in this paper) and the third belonging from the Rio de
Janeiro Municipality Health Secretariat ERC (CAAE
59009416.6.3002.5279).
Results
It was found a total of 3,862 individuals with a potential
OC lesion in the SISREG. A total of 266 (6.9 %) individ-
uals were confirmed as OC. The average age was 52.3
years old for those with no cancer and 62.3 years old in
the OC group and there were no cases of oral cancer
under 15 years old. Males’ percentage was higher among
those with OC (64.7 %) and the percentage of white indi-
viduals was 36.1 % and 27.5 % among patients with and
with no OC respectively (Table 1).
From the total 4.764 records, 64.3 % were classified as
blue and 15.1 % as red. It was found 27.2 % records as
red risk among the male while 9.2 % among the female.
Among those with OC 45.2 % were classified as red risk,
while this percentage was 12.9 among those with no OC.
Among those records diagnosed as OC and risk classi-
fied as red the majority (77.1 %) were male (Table 2).
The majority of the patients that received a diagnosis of
cancer also received a red risk stratification.
The likelihood (adjusted OR) of having cancer and re-
ceiving a risk score yellow or red was 3.0 [95 %CI 2.2–
4.3]. Males, individuals 60 years old and greater, and
white were more likely to receive a diagnosis of cancer,
with OR respectively of (OR 2.7 [95 %CI 2.0–3.8]). (1.8
95 % CI 1.3–2.5) and (OR = 1.4 [95 %CI 1.0–1.9)
(Table 3).
The average TTI, which is time from the first request
and the appointment for those with no OC was 47.1
days and median of 23 days. Meanwhile, for patients
with OC confirmed, the average TTI was 59.1 days and
median of 50.5 days until being admitted in a cancer
hospital and the difference was significant (p = 0.007)
(Table 4). The TTI average was higher for individuals
older than 60 years old, male, and white individuals and
for risk classification red and yellow.
It was noticed that the TTI medians also followed the
same patters as the means, nevertheless with greater dif-
ference. While in average none of these differences were
statistically significant, the median of individuals classi-
fied as high risk was significantly (p = 0.044) higher than
those with low risk.
Discussion
Oral Cancer (OC) had a prevalence of 6.9 % in this
study, with greater proportions in the older, white and
males. The risk classification was the main important
factor in the likelihood of having OC diagnosis. Half of
the patients with oral cancer had treatment initiation
within 51 days and the median of individuals classified
as high risk was significantly higher than those with low
risk. No gender and race disparities in terms of TTI
were found.
Since 2004, with the expansion of the National Oral
Health Policy (PNSB) [3], Brazil has implemented its
strategies for prevention, early diagnosis, and control
of OC. The PNSB implementation requires easy ac-
cess to oral health services through the Family Health
Strategy (ESF) and the Oral Health Teams as PHC in-
terventions [23].
Articulated actions offered in a timely and resolu-
tive way can prevent the late diagnosis and improve
patients’ prognostics. In this sense, the OC approach
must include the regular screening for early detection;
assessment of oral lesions (active search, home visits,
Table 1 Demographic characteristics by oral cancer diagnosis,
SISREG. Rio de Janeiro Municipality, January 2013 to September
2015
Variables Oral cancer
No (N=3596) Yes (N=266) Total (N=3862)
N % N % N %
Age (mean in years) 52.3 62.3 53
Age (range of years)
<1 3 0.1 0 - 3 0.1
>=1 e <15 240 6.7 0 - 240 6.2
>=15 e <60 1820 50.6 104 39.1 1924 49.8
>=60 e <85 1446 40.2 151 56.8 1597 41.4
>=85 87 2.4 11 4.1 98 2.5
Sex
female 2263 62.9 94 35.3 2357 61.0
male 1333 37.1 172 64.7 1505 39.0
Race
asian 425 11.8 22 8.3 447 11.6
white 988 27.5 96 36.1 1084 28.1
indigenous 2 0.1 0 - 2 0.1
brown 771 21.4 47 17.7 818 21.2
black 350 9.7 26 9.8 376 9.7
No information 1060 29.5 75 28.2 1135 29.4
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specific campaigns); monitoring of suspected cases;
referral services for confirmed cases; and the estab-
lishment of partnerships for prevention, diagnosis,
treatment, and recovery with universities and other
organizations [24].
Public health programs are expected to provide
adequate responses to the health problems for
which they are intended and evaluated for imple-
mentation, access, and outcomes, guiding decision-
making [25]. Thus, it is worth asking about the
offer of oral health care within the scope of the
PNSB in primary, secondary and specialized health
services and how patients have covered the services
they need.
There is a higher likelihood of receiving a diagnosis of
OC for individuals over 60 years old, males, white, which
corroborates with results of other studies regarding the
profile of patients and location of lesions [26, 27].
When OC diagnosed patients were referred through
the SISREG system, the average time to start cancer
treatment (average of 50 days and median of 59 days) is
within the federal legal time period of 60 days [28].
Nevertheless, the Rio de Janeiro municipality health
regulation has a more restrictive TTI rule that
Table 2 Distribution of estimated risk of SISREG records by selected variables by diagnosed oral cancer, SISREG. Rio de Janeiro
Municipality, January 2013 to September 2015
Variable Oral cancer Total
No Yes
# % # % # %
Total - - 4439 100.0 325 100.0 4764 100.0
Estimated risk BLUE - elective care 2941 66.3 121 37.2 3062 64.3
GREEN - not urgent 213 4.8 1 0.31 214 4.5
YELLOW - urgent 711 16.0 56 17.23 767 16.1
RED - emergent 574 12.9 147 45.23 721 15.1
Sex BLUE - elective care Female 1474 65.4 47 46.1 1521 3.1
Male 781 34.6 55 53.9 836 6.6
GREEN - not urgent Female 133 71.9 1 100.0 134 0.7
Male 52 28.1 0 0.0 52 -
YELLOW - urgent Female 391 60.3 19 42.2 410 4.6
Male 257 39.7 26 57.8 283 9.2
RED - emergent Female 265 52.2 27 22.9 292 9.2
Male 243 47.8 91 77.1 334 27.2
FH Federal Hospital, SH State level hospital, UH University Hospital
Table 3 Study population demographic characteristics associated with the oral cancer diagnosis, SISREG. Rio de Janeiro Municipality,
January 2013 to September 2015
Variables (dummy) Cancer Oral






OR (95% CI)No Yes
Risk Blue or Green 2440 (67.9 %) 103 (38.7 %) 2543 (65.8 %) p = 0.000 p = 0.000
Yellow or Red 1156 (32.1 %) 163 (61.3 %) 1319 (34.2 %) 3.3 (2.6–4.3) 3.0 (2.2-4.0)
Total 3596 (100.0%) 266 (100.0%) 3862 (100.0%)
Sex Female 2263 (62.9 %) 94 (35.3 %) 2357 (61.0 %) p = 0.000 p = 0.000
Male 1333 (37.1 %) 172 (64.7 %) 1505 (39.0 %) 3.1 (2.4–4.0) 2.7 (2.0-3.8)
Total 3596 (100.0%) 266 (100.0%) 3862 (100.0%)
Age >=15 e < 60 1820a (54.3 %) 104 (39.1 %) 1924 (53.2 %) p = 0.000 p = 0.000
>=60 1533a (45.7 %) 162 (60.9 %) 1695 (46.8 %) 1.8 (1.4–2.4) 1.8 (1.3–2.5)
Total 3353 (100.0%) 266 (100.0%) 3619 (100.0%)
Race Not white 1548 (61.0 %) 95 (49.7 %) 1643 (60.2 %) p = 0.003 p = 0.050
white 988 (39.0 %) 96 (50.3 %) 1084 (39.8 %) 1.6 (1.6–2.2) 1.4 (1.0 -1.9)
Total 2536 (100.0%) 191 (100.0%) 2727 (100.0%)
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establishes that patients diagnosed with cancer must be
referred by PHC, via SISREG, for specialized care. Other
studies that evaluated TTI in Brazil found it as 1–3
months [18], 23 days mean (1-116 days range) [17] and
71.1 days (1-142 days range) [19]. Nevertheless, they all
used small hospital-based samples. A study from INCA
found a TTI below 60 days 43.8 % and 56.2 for male and
female patients, respectively in the Southeast Region
[29]. Studies carried out in foreign countries found an
average TTI of 30 days [30] and greater than 46 days
[31] for 25 % of treated patients, a time considered
worrying for the disease outcome.
When his risk is classified as high (red), this requires
priority scheduling of up to 30 days. Yellow, scheduling
up to 90 days, green and blue, scheduling up to 180 days
or more, respectively, was found not to adhere [32]. As
well established in the literature, the TTI can be decisive
for the progress and incurability of the disease [33, 34],
and preventable delays should be avoided.
Among the causes for the time elapsed between the
first registration of the patient in the regulation system
and the beginning of treatment, one can assume the flow
instituted by the health system since the PHC. For cases
registered as having the highest risk for OC (red and yel-
low risk), the time to start treatment was longer than for
the others. Serra et al. also found an inadequate
organization of referral and counter-referral activities,
with many of the patients not being referred by the offi-
cial system, which produces double entry into the sector,
resulting in losses or delays in some visits [35]. The op-
posite, such as decentralization and regionalization of as-
sistance for cancer treatment, facilitate patient access,
with an increase in the number of hospitalizations in
some locations [36].
Another relevant factor is the difficulty in identifying a
suspected lesion of these tumors, being most often diag-
nosed when its size exceeds 2 cm [37]. This situation
and other factors can lead to a delay in diagnosis, as in-
dicated by Costa-Jr and Serra [28]: few and nonspecific
symptoms, patients’ lack of knowledge about the disease,
little familiarity of general practitioners who work in pri-
mary care with the diagnosis of cancer and difficulty in
accessing the health system [38]. The late diagnosis is
reflected in the most frequent treatments at the referral
hospital, radiation therapy associated with surgery,
knowing that the best prognosis is referred to as only
surgical treatment [38].
As limitations it is important to mention that the
regulation system does not include staging and other
clinical information that would be helpful and could
support and inform policy changes needed in the regula-
tion and referral. Also, the SISREG is a secondary data-
base and as such, can contain misclassifications of cases.
Finally, only registered individuals that had their treat-
ment through SUS were analyzed.
Conclusions
In this study, it was found that being male, white, and
older than 60 increased the likelihood of having a diag-
nosis of oral cancer. The time to initial treatment was
higher for those with confirmed OC diagnosis; neverthe-
less, TTI is within the time expectation established by
Law in the National Health System and there were no
disparities regarding age, race and gender. The risk clas-
sification system seems to not be a factor for speeding
up the treatment, furthermore the median TTI of indi-
viduals with high-risk classification was higher and rea-
sons for that should be clarified in future studies.
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